Biological Therapeutics Product Development Subject Matter Expert Consulting Services

Closed Solicitation Posted

Solicitation number
75N95024Q00252
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse is seeking to acquire high-level subject matter expert (SME) consulting support for translational product development activities at the National Institute of Neurological Disorders and Stroke (NINDS). The purpose is to provide critical SME support across a broad range of NINDS' biologics discovery and development programs. The evaluation will be conducted in two phases, with Phase One assessing personnel qualifications, price, and past performance, and Phase Two evaluating technical approach and communication skills through oral presentations. The solicitation has a due date of May 17, 2024.

This acquisition is not set aside for small businesses. The anticipated contract type is labor hour, with a one-year base period and two one-year option periods. The government anticipates funding an estimated 100 labor hours annually, with up to an additional 3,800 optional hours that may be exercised. Travel expenses will also be reimbursed. The place of performance will be at the contractor's facility.

Notice text

3 versions

Update #3 · Latest ·

Amendment 02: Q&A updated with additional question and response.

Amendment 01: (1) Quotation submission deadline extended to May 17, 2024 at 5 pm ET; (2) Non-scored evaluation factor added for small business subcontracting; (3) Attachments for Government responses to vendor questions, amended combined syopsis/solicitaiton, and amended technical evaluation criteria uploaded.

The purpose of this requirement is to acquire high-level subject matter expert (SME) support for translational product development at the National Institute of Neurological Disorders and Stroke (NINDS). This requirement provides support that is critical to the broad range of NINDS translational product development activities that are in-process, planned, and evolving.

Please refer to Attachment #1 - Statement of Work (SOW) for complete details and specifications.

Update #2 ·

Amendment 01: Quotation submission deadline extended to May 17, 2024 at 5 pm ET. Attachments for Government responses to vendor questions, amended combined syopsis/solicitaiton, and amended technical evaluation criteria uploaded.

The purpose of this requirement is to acquire high-level subject matter expert (SME) support for translational product development at the National Institute of Neurological Disorders and Stroke (NINDS). This requirement provides support that is critical to the broad range of NINDS translational product development activities that are in-process, planned, and evolving.

Please refer to Attachment #1 - Statement of Work (SOW) for complete details and specifications.

Update #1 ·

The purpose of this requirement is to acquire high-level subject matter expert (SME) support for translational product development at the National Institute of Neurological Disorders and Stroke (NINDS). This requirement provides support that is critical to the broad range of NINDS translational product development activities that are in-process, planned, and evolving.

Please refer to Attachment #1 - Statement of Work (SOW) for complete details and specifications.

Files

Show all 12

Similar open opportunities

Opportunity Agency Set-aside Responses due
ATT 1 Senior _Advisor_2026_Statement of Work - Biological therapeutics EOC Support- 7571PS27Q00017 Bethesda, Maryland, United States · NAICS 541690 — Total Small Business
2 Senior Advisors Services for the NINDS Blueprint Neurotherapeutic Network for Small Molecules External Oversight Committee (EOC) Subject Matter Expert (SME) Services Bethesda, Maryland, United States · NAICS 541690 — Total Small Business
Senior Advisor Subject Matter Expert (SME) with Patient Advocacy Expertise for the NINDS Ultra-rare Gene-based Therapy (URGenT) Network Rockville, Maryland 20852, United States · NAICS 541690 — Total Small Business
Senior Advisor 2 for Biological Therapeutics Development to act as External Oversight Committee (EOC) Subject Matter Expert (SME) Services. Bethesda, Maryland, United States · NAICS 541690 — No set-aside
Senior Advisor Subject Matter Expert (SME) with Pharmaceutical Development and Pain Expertise for the NINDS Bethesda, Maryland 20892, United States · NAICS 541690 Office of the Assistant Secretary for Administration Total Small Business

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors